SAfeguarding female FERtility -development of human-relevant in vitro tools for reproductive toxicity

SAFER aims to develop innovative, animal-free assays for assessing reproductive toxicity in women, using advanced technologies to identify harmful chemicals and promote safer environments.

Subsidie
€ 2.000.000
2024

Projectdetails

Introduction

Chemical health risk assessment has failed to safeguard fertility in women. Women and their oocytes are exposed to pervasive mixtures of human-made chemicals that correlate with reproductive ageing and infertility. Only 0.5% of the chemicals on the European market have been well characterized for health risks, and reproductive toxicity in women is typically not covered due to missing tools.

European Growth Strategy

The new European Growth Strategy aims at sustainable growth, zero-pollution, and safe chemicals. While the need for increased chemical testing is tangible, there is a movement to phase out animal experiments. This creates a huge challenge to deliver on the vision of a safe and toxic-free environment.

Project Overview

Here, I will develop new high-content assays for reproductive toxicity in women. SAFER is built on my exceptional ovary biobank, established stem cell lines, and multi-omics technologies.

Methodology

Using chemically exposed ovarian tissue and stem cell-derived blastoid cultures, SAFER will map mechanisms mediating toxicity by high-resolution epigenetic and transcriptomic analyses. Model chemicals are chosen based on:

  1. Ubiquitous presence in women
  2. Significant associations to decreased ovarian function, as shown by my cohort studies.

The identified mechanisms will be tailored into reporter genes that I will insert into new immortalized human ovarian cells as well as stem cells, and develop into high-content screening assays.

Expected Outcomes

The product of SAFER is novel in vitro tools for screening of female reproductive toxicants. Taken together, SAFER sets an example for animal-free derivation of assays for chemical safety assessment.

Impact

SAFER tools will contribute to the identification and restriction of chemicals that pose a hazard to women’s health. This is an important step in the global movement towards a non-toxic, safe environment.

Conclusion

Starting a family is a basic human right, and whether to have a child or not should be decided by the prospective parents, not by the chemicals in their environment.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-10-2024
Einddatum30-9-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • KAROLINSKA INSTITUTETpenvoerder

Land(en)

Sweden

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

A new ERA for Environmental Risk Assessment: Chirality as a tool towards environmentally safe pharmaceuticals

ERA|ARE aims to establish a leading research group to mitigate pharmaceutical contamination in aquatic environments by exploring the enantioselectivity of fluoroquinolones to enhance environmental safety.

€ 1.499.950
ERC STG

Representative, Reliable and Reproducible in vitro Models of the Human Testes

The project aims to develop a reliable preclinical model of human testes using tailored hydrogels to improve male infertility treatments through high-throughput experimentation and automated analysis.

€ 1.499.980
ERC POC

Human blastoids: a drug discovery platform for women’s reproductive health

BLASTOID-DISCOVERY aims to utilize human blastoids as a scalable and ethical model for drug discovery to enhance women's reproductive health and reduce development costs.

€ 150.000
ERC STG

Understanding the impact of environmental POLlution on the adaptive Immune System

This project aims to utilize advanced omics technologies to investigate the low-concentration bioactivity of PFAS chemicals and their potential role in non-communicable diseases.

€ 1.499.749